Clinical trial
A Crossover Bioavailability Clinical Trial of Parenteral Pyronaridine and Artesunate
NCT05929157 is registered in ClinicalTrials.gov with Centre de Recherche Médicale de Lambaréné as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Crossover Bioavailability Clinical Trial of Parenteral Pyronaridine and Artesunate
- Lead sponsor
- Centre de Recherche Médicale de Lambaréné
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- September 1, 2023
- Completion date
- June 30, 2025
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
severe malarial treatment